In what is certainly a new high or a new low for this podcast, we explore how to calculate the “Kardashian Index” of your KOLs and scientific leaders.
Johnson & Johnson’s Medical Affairs team is transforming strategy with data-driven insights, moving beyond traditional approaches to identify key opinion leaders, improve advisory board diversity, and enhance patient journey mapping. With H1’s analytics, they are shifting from quantity to quality in engagements, advancing health equity, and leveraging AI for smarter decision-making.
Introducing the Foundations in Medical Affairs Certificate Program, an essential component of the MAPS eCademy Learning Journey, specifically designed to elevate your understanding of critical concepts and practices in Medical Affairs. With courses tailored to a wide range of fields, Ecademy fosters skill development and professional growth in a collaborative digital environment.
The objective of this article is to discuss the paradigm shift in how companies plan for and deliver on the “long tail” of a drug’s impact even after Loss of Exclusivity (LoE) – a process known as lifecycle management (LCM).
In this webinar, we will share how to realize the potential of insights starts with a focus on strategy
In this webinar we discuss the best practices and hurdles to implement tangible medical affairs impact measurement.
In this On-demand webinar, we discuss key considerations for driving our function forward on impact, initiating conversations on impact, and practical considerations for improving the evaluation of impact.
